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SOBP Is Mutated in Syndromic
and Nonsyndromic Intellectual Disability and Is
Highly Expressed in the Brain Limbic System
Efrat Birk,1 Adi Har-Zahav,1 Chiara M. Manzini,2 Metsada Pasmanik-Chor,3 Liora Kornreich,4
Christopher A. Walsh,2 Konrad Noben-Trauth,5 Adi Albin,6 Amos J. Simon,7 Laurence Colleaux,8
Yair Morad,1,9 Limor Rainshtein,6 David J. Tischfield,2 Peter Wang,2 Nurit Magal,6 Idit Maya,6
Noa Shoshani,1 Gideon Rechavi,1,7 Doron Gothelf,1,10 Gal Maydan,11 Mordechai Shohat,1,6,12
and Lina Basel-Vanagaite1,6,13,*
Intellectual disability (ID) affects 1%–3% of the general population. We recently reported on a family with autosomal-recessive mental
retardation with anterior maxillary protrusion and strabismus (MRAMS) syndrome. One of the reported patients with ID did not have
dysmorphic features but did have temporal lobe epilepsy and psychosis. We report on the identification of a truncating mutation in the
SOBP that is responsible for causing both syndromic and nonsyndromic ID in the same family. The protein encoded by the SOBP, sine
oculis binding protein ortholog, is a nuclear zinc finger protein. In mice, Sobp (also known as Jxc1) is critical for patterning of the organ
of Corti; one of our patients has a subclinical cochlear hearing loss but no gross cochlear abnormalities. In situ RNA expression studies in
postnatal mouse brain showed strong expression in the limbic system at the time interval of active synaptogenesis. The limbic system
regulates learning, memory, and affective behavior, but limbic circuitry expression of other genes mutated in ID is unusual. By
comparing the protein content of the þ/jc to jc/jc mice brains with the use of proteomics, we detected 24 proteins with greater than
1.5-fold differences in expression, including two interacting proteins, dynamin and pacsin1. This study shows mutated SOBP involve-
ment in syndromic and nonsyndromic ID with psychosis in humans.Intellectual disability (ID) affects 1%–3% of the general
population.1,2 Syndromic ID is characterized by ID accom-
panied by major physical abnormalities, dysmorphism, or
neurological abnormalities, whereas nonsyndromic ID is
characterized by cognitive impairment without any addi-
tional features. Progress in the identification of genes asso-
ciated with ID has highlighted the fact that the distinction
between syndromic and nonsyndromic ID appears to be
blurred, because mutations in some genes can result in
both syndromic and nonsyndromic forms of cognitive
impaiment.3,4 To date, mutations in only six genes have
been identified to cause nonsyndromic autosomal-reces-
sive ID—these are PRSS12 (MIM 606709), CRBN (MIM
609262), CC2D1A (MIM 610055), GRIK2 (MIM 138244),
TUSC3 (MIM 601385), and TRAPPC9 (MIM 611966).5–10
We recently reported on a syndrome characterized by
autosomal-recessive ID, dysmorphic features, and stra-
bismus, which we have named the MRAMS syndrome
(for mental retardation, anterior maxillary protrusion,
and strabismus).11 Interestingly, one of the seven reported
patients with ID did not have dysmorphic features but did
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694 The American Journal of Human Genetics 87, 694–700, Novemba common finding in this family and was present in 6
out of 7 individuals; it was resolved with conservative
treatment in all but one patient. Patient IV-9 (Figure 1A)
was diagnosed with esotropia and amblyopia in the left
eye at the age of 6 years. Vision was reduced to 6/18 in
the left eye. Cycloplegic refraction revealed hypermetropia
of þ4.0 diopters in the right eye and þ4.5 diopters in the
left eye. Glasses with full cycloplegic correction were
prescribed and patching of the right eye was initiated.
Vision was normalized, but the esotropia persisted; there-
fore, strabismus surgery was performed. Brainstem audi-
tory evoked response examination in patient IV-1 showed
mild cochlear hearing loss of 30–40 dB. On the MRI of this
patient, no gross cochlear abnormalities were observed. In
patient IV-5, premaxillary prominence, dental crowding,
and strabismus were absent, and this patient has a slightly
higher level of functioning together with psychosis and
seizures. At 11 years of age he developed seizures, and
from 13 years onward he developed increasingly severe
psychotic symptoms; he started talking to himself and
would respond to auditory and visual hallucinations for
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Figure 1. Gene Mapping and Mutation Identi-
fication
(A) Pedigree, haplotyping, and segregation of
mutation in the family. The proband is indicated
by an arrow. For mutation detection by restric-
tion analysis, amplification of a 669 bp fragment
from genomic DNA was performed with the use
of primers A and B. The mutation introduces
a Dde1 restriction site, which digests the 669 bp
fragment into 310 bp, 195 bp, and164 bp frag-
ments. The reaction products were separated by
electrophoresis on 3% NuSieve/1% agarose gels.
(B) Candidate region on chromosome 6q16.3-
q21, with the list of candidate genes.
(C) Sequence analysis in a patient, heterozygous
carrier, and control individual. M, mutant allele;
C, carrier;WT, homozygous wild-type. DNA from
individual IV-4 was not available for mutation
segregation analysis.be fragmentation of his thought processes. He became
easily frustrated and exhibited recurrent aggressive out-
bursts. Psychiatric symptoms are known to be a part of
several syndromes, including velo-cardio-facial syndrome
(MIM 192430), fragile X syndrome (MIM 300624),
MRX30 (MIM 300558), and others.
In order to identify the causativemutation in this family,
after informed consent was obtained from all family mem-
bers or their legal guardians (in accordance with a protocol
approved and reviewed by the National Committee for
Genetic Studies, Israel Ministry of Health), we genotyped
400 microsatellite markers from the ABI PRISM linkage
mapping set, version 2.5 (Applied Biosystems, Foster City,
CA, USA). All of the patients exhibited a large continuous
segment of homozygosity on chromosomal region 6q21.
A common homozygous disease-bearing haplotype was
constructed; informative recombinations delineated a
critical region of 9.8 Mb between the polymorphic markers
D6S449 and D6S404 (Figure 1A). Individual IV-5, with
nonsyndromic ID, showed the same disease-associated
haplotype. Through SNP genotyping using AffymetrixThe American Journal of HumanHuman Mapping 50k Xba 240 arrays on
individuals IV-1, IV-2, IV-4, and IV-7, the
candidate interval was reduced to the
region between markers D6S449 and
rs2235989. There was only one homozy-
gosity region shared by all of the patients;
there were no homozygosity regions shared
by all individuals apart from individual
IV-5 (Figure S1, available online). The two-
point LOD score calculations were per-
formed with the program SUPERLINK12
and yielded a Zmax score of 4.45 at recombi-
nation fraction (q) 0.00 (Table S1). The
candidate region contained 36 known or
predicted genes (Figure 1B), as identified
with the use of available databases (NCBI
and UCSC Genome Browser, March 2006
version). All exons including exon-intronjunctions of the following candidate genes were
sequenced: GRIK2 (MIM 138244), LIN28B (MIM 611066),
BVES (MIM 604577), POPDC3 (MIM 605824), PREP (MIM
600400), ATG5 (MIM 604261), RTN4IP1 (MIM 610502),
PDSS2 (MIM 610564), SCML4, OSTM1(MIM 607649),
NR2E1 (MIM 603849), SNX3 (MIM 605930), FOXO3A
(MIM 602681), ARMC2, SESN1 (MIM 606103), CD164
(MIM 603356), LACE1, PPIL6, SMPD2 (MIM 603498),
ZBTB24, C6ORF199, GPR6 (MIM 600553), WASF1 (MIM
605035), CDC40 (MIM 605585), and DDO (MIM 124450).
No pathogenic sequence changes were found. Sequencing
of SOBP was performed with the use of ten primer pairs
(Table S2). In this gene, we identified a homozygous C>T
change in nucleotide 1981 of exon 6 (c.1981C>T)
(NM_018013.3) (Figure 1C), which creates an early stop
codon that causes the truncation of 212 residues of the
873 amino acids of the protein (p.Arg661X). SOBP muta-
tion screening was performed on genomic DNA by PCR
amplification with primer pair 7 (Table S2). The mutation
segregated with the disease (Figure 1A) and was not
observed in 300 control chromosomes of Israeli ArabGenetics 87, 694–700, November 12, 2010 695
Figure 2. Bioinformatics Analysis of the Genomic Conservation of the SOBP and SOBP Domain and Motif Structure
(A) ECR browser analysis on human (hg18) was performed to show SOBP conservation between human and various species (danio,
tetradon, fugu, Xenopus, gallus, rat, mouse, dog, rhesus, and chimp). Genomic conservation of exons (blue) and introns (orange), as
well as the UTR (yellow) and repeats (green), is visualized. Layer height presents the percentage of identity (sequence conservation).
Two different gene transcripts are shown at the bottom. The blue arrow shows a C>T change in nucleotide 1981 of exon 6 in SOBP.
(B) Domain properties for SOBP (A7XYQ1; SOBP_HUMAN) were obtained from UniProt. Two FCS-type zinc fingers (MYM-type zinc
finger with FCS sequence motif, PF06467) and two proline-rich regions (IPR000694) are shown (red and yellow, respectively). NLS local-
ization is also presented (navy). In addition, DNA and RNA binding motifs were predicted by the RNABindR server (light blue). The
results from the BindN, PPRint, and MEME servers agree with those from the RNABindR server (data not shown). The blue arrow repre-
sents residue 661, in which the reported mutation occurred, causing truncation of SOBP.individuals. mRNA from the lymphoblasts of one of the
patients was successfully amplified, indicating that mutant
mRNA is not completely degraded (data not shown).
In order to determine the frequency of SOBP involve-
ment, when mutated, in other families with autosomal-
recessive ID, homozygosity at the 6q21 locus was tested
by genotyping with the Affymetrix GeneChip Mapping
250K Array in 22 independent consanguineous patients
presenting with isolated or mildly syndromic ID. However,
no patient was found to be compatible with linkage to this
locus.
The SOBP structure was described with the use of the
UCSC (GRCh37/hg19, February 2009), NCBI (build 37.1,696 The American Journal of Human Genetics 87, 694–700, NovembAugust 2009), and Ensembl (GRCh37, February 2009)
genome browsers (Figure 2A).13 DNA and RNA binding
motifs were predicted by the following servers: RNABindR,
BindN, PPRint, and MEME. The human SOBP (sine oculis
binding protein ortholog, also known as Jackson circler
protein 1 [JXC1]; RefSeq NM_018013, GeneID: 55084)
encodes a zinc finger protein that is located on human
chromosome 6q21 and covers 171,192 bp of genomic
DNA. The mRNA size is 6227 bp. The SOBP promoter
consists of a distinct CpG island region; another CpG
island region is clearly found in exon 6 and is predicted
with high probability to be an additional promoter region.
There are seven exons, the last of which is the untranslateder 12, 2010
Figure 3. Mouse Sobp mRNA Is Highly Expressed in the Limbic System
(A and B) In situ hybridization on coronal (A) and parasagittal (B) sections of P10 murine brains show that Sobp is expressed throughout
the brain, with the strongest expression in the cortex (ctx), especially in layer V, the hippocampus (hipp), the piriform cortex (pyr ctx),
the mediodorsal nucleus of the thalamus (MDn), the anterior olfactory nucleus (AON), and the mitral cell layer in the olfactory bulb
(mcl). Scale bars represent 500 mm.
(C) Strong Sobp expression is also observed in the amygdala (amy) and the hypothalamus (hyp). Scale bars represent 100 mm.
(D) Cortical expression is strong throughout development, with the highest levels of expression in layers II/III and V and in the subplate
(SP). SVZ, subventricular zone. Scale bar represents 100 mm.region (UTR). Genomic conservation analysis shows that
exons are highly conserved among vertebrates, whereas
introns are conserved mainly within primates (Fig-
ure 2A). Transcript variants encode the main 873 amino
acid protein (transcript 1) (NP_060483) and a shorter
variant of 232 amino acids (transcript 2) (Figure 2A). It
contains two FCS-type zinc fingers (MYM-type Zinc finger
with FCS sequence motif, PF06467) and two proline-rich
(PR) regions (IPR000694) (Figure 2B). There are many
species with orthologs of the human protein. In the
UCSC database, the chimp SOBP protein is a 668 residue
protein, and the human is an 874 residue protein. The
chimp protein divides into two parts. The first section is
1–409, with 99% identity to the human protein. Then
there is a missing section in the chimp, found only in
the human, and then comes another fragment (chimp
410–668; human 696–874) with 87% identity. Human
SOBP is expressed in various tissues. There is a clear nuclear
localization signal (NLS) at residues 9–24 and another
putative NLS around residue 750. The motifs found in
the protein are depicted in Figure 2B. Predictions for RNA
and DNA binding motifs by different servers show that
SOBP contains RNA binding motifs around and including
residue 661 (Figure 2B). Interestingly, a search for DNAThe Americanbinding motifs using various bioinformatics databases
did not show such motifs in SOBP. Truncation of SOBP
after residue 661 causes elimination of a PR2 domain as
well as possible NLS motifs and an RNA binding region,
which may be important for the functioning of the pro-
tein. Protein-conservation analysis by the ConSeq server
showed high sequence conservation and functionality of
the C-terminal part of the protein; the N-terminal part
is less conserved and has fewer functional residues
(Figure S2).
In order to establish whether Sobp expression in the
developing and adult brain could provide some insight
into the cause of cognitive impairment, we performed a
complete developmental characterization of Sobp mRNA
expression in the murine brain by in situ hybridization.
For in situ hybridization, plasmid templates for riboprobe
synthesis were generated by subcloning a fragment of
Sobp PCR amplified from IMAGE cDNA clone 10083890
containing a 493 bp sequence corresponding to nucleotide
positions 21–514 of the Sobp coding sequence. In situ
hybridization was performed as described by Tucker et al.14
Sopb was present at embryonic day (E) 14 throughout the
developing brain, with intense staining in the cortical
plate (Figure 3). During postnatal (P) development (P0,Journal of Human Genetics 87, 694–700, November 12, 2010 697
Table 1. Proteins with Greater than 1.5-fold Differences in
Expression
Mus musculus Protein Name
NCBI
Reference
Sequence
Ratio
of þ/jc
to jc/jc
Dynamin 487851 1.55
Pacsin1 148690599 1.59
Dihydropyrimidinase-like 2 40254595 1.86
Syntaxin binding protein 1 17225417 1.82
Collapsin response mediator protein 1
isoform 2
40068507 1.52
Solute carrier family 25 (mitochondrial
carrier, Aralar), member 12
27369581 1.51
Enolase 3, beta muscle, isoform CRA_a 148680653 2.69
Unnamed protein product 12845061 2.77
Acyl-CoA thioesterase 7 19923052 1.56
Tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein,
epsilon polypeptide
31981925 1.51
Synaptosomal-associated protein 25 6755588 1.62
NmrA-like family domain containing 1 24431937 1.64
Actin related protein 2/3 complex,
subunit 2
112363072 1.58
Phosphoglycerate mutase 1 114326546 1.52
Carbonic anhydrase III 31982861 3.72
ATP synthase, Hþ transporting,
mitochondrial F0 complex, subunit d
21313679 3.79
Hypothetical protein LOC66469 27754130 1.66
Growth hormone 6679997 5.96
ATP synthase, Hþ transporting,
mitochondrial F1 complex, delta
subunit, isoform CRA_a
148699643 1.57
Unnamed protein product 74150634 1.96
Parvalbumin 53819 1.88
PREDICTED: similar to expressed in
non-metastatic cells 1, protein
(NM23A) (nucleoside diphosphate)
73963227 3.23
Beta-globin 156257681 1.56
Heat-responsive protein 12 40807498 2.06P10, and adult), Sobpwas also expressed in all neurons, but
a striking and intense expression pattern was especially
evident in the limbic system, with the highest expression
levels throughout layer V neurons in the cortex, the hippo-
campus, the pyriform cortex, the dorsomedial nucleus of
the thalamus (Figures 3A and 3B), the amygdala, and the
hypothalamus (Figure 3C). Cortical expression was strong
throughout development, with no clear dorsoventral or
rostrocaudal gradient, the highest levels at P10 in layers
II/III and V and in the subplate (Figure 3D). Relatively
strong expression was also observed in themitral cells layer
and anterior olfactory bulb (Figure 3B) and in the Purkinje
cell layer in the cerebellum (not shown). We observed
a striking and very specific expression of Sobp in the limbic
system postnatally, corresponding to the time window of
active synaptogenesis. It is known that on mouse P7 there
is a period of significant synaptogenesis for neural-circuit
formation and the expression of many genes encoding
synaptic proteins and receptors.15 Another protein that
has been found to be expressed in the limbic circuitry so
strikingly is limbic system-associated membrane protein
(LAMP).16 Because the circuit showing the highest Sobp
expression regulates learning, memory, and affective
behavior in humans, we suggest that disruption of SOBP
in the limbic system during synaptogenesis leads to the
abnormal cognition observed in the patients. The patho-
genesis of strabismus in the patients is unclear. Because
cortical Sobp expression is uniform, we cannot explain the
origin of the strabismus on the basis of dynamic changes
of Sobp expression levels in the visual cortex. Regulation
of eye convergence may be affected at levels other than
the cortex. Interestingly, in Drosophila, ectopic expression
of Sobp leads to structural aberrations in the adult eye.17
In mice, Jxc1/Sobp is critical for cochlear growth, cell
fate, and patterning of the organ of Corti.18,19 Mice
mutants also exhibit erratic circling behavior and have
no vestibular evoked potentials. In contrast to mutant
mice, one of our patients has a subclinical cochlear hearing
loss of 30–40 dB but does not show any vestibular abnor-
malities or gross cochlear abnormalities. In order to gain
some insight into the cause of cognitive impairment, we
compared the protein content of the þ/jc to jc/jc mice
brains by using proteomics. For the proteomics analysis,
proteins from brain tissue from each of þ/jc and jc/jc
mice were extracted and 300 mg of protein lysate was
used for the analyses. Two-dimensional gel electropho-
resis, spot identification, and mass spectrometry were per-
formed by Applied Biomics. Proteins with greater than
1.3-fold differences between þ/jc and jc/jc samples were
identified by mass spectrometry. Protein lists were
analyzed with the bioinformatics tool DAVID. Gene
Ontology (GO) characterization of the proteins was per-
formed by the tools GOTM, DAVID, and PANTHER. Func-
tional annotation was performed with the use of mouse
brain genes as background (MGI database). We detected
24 differentially expressed proteins with greater than 1.5-
fold differences between þ/jc and jc/jc samples (Table 1).698 The American Journal of Human Genetics 87, 694–700, NovembAlthough these results should be further investigated and
validated in additional studies, there are several interesting
observations. Two of the differentially expressed proteins,
pacsin1 and dynamin, may be involved the same cellular
pathway—the rat ortholog of pacsin1 was identified as
a synaptic protein that interacts with dynamin.20 Dyna-
min is a neuron-specific guanosine triphosphatase that is
important in endocytosis at the fission step of nascent
clathrin-coated vesicles from the plasma membrane.21
In mice lacking dynamin, synaptic vesicle endocytosis is
severely impaired during strong exogenous stimulation
but resumes efficiently when the stimulus is terminated,
suggesting that dynamin is necessary during high levelser 12, 2010
of neuronal activity.22 In the rat brain, downregulation of
dynamin in cultured hippocampal embryonic neurons
leads to impairment of the formation of minor and axon-
like processes in a dose-dependent manner.23 Another
differentially expressed protein, parvalbumin, encoded
by pvalb, belongs to the family of calcium-binding pro-
teins. Parvalbumin-positive neurons are observed in the
hippocampal cells; they constitute an abundant subpopu-
lation of cells that express GABA.24 During the develop-
ment of the rat neocortex and hippocampus, Pvalb
mRNA expression is visible after P6.25 As with Sobp, by
P10 Pvalb expression is detected mainly in layer V of the
neocortex and in the hippocampus; by P14 there is a
marked increase of expression in the entire neocortex
and in the hippocampus. Significant functional annota-
tions of differentially expressed proteins, withmouse brain
genes used as background, were for axon (GO: 0030424)
and neuron (GO: 0043005) projection, axon guidance,
synaptic vesicle traffic, 5HT3- and 5HT4-type receptor-
mediated processes, the alpha and beta3 adrenergic recep-
tors, the cortocotropin releasing factor, and sugar metabo-
lism (results not shown).
In summary, we describe a gene involved in human
cognition, SOBP, that shows the highest expression in the
limbic system postnatally and that, when mutated, causes
syndromic and nonsyndromic autosomal-recessive ID.Supplemental Data
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